The condensed balance sheets for kaléo at June 30, 2016 and December 31, 2015 and condensed statements of operations for the three and six months ended June 30, 2016 and 2015, as reported to the Company by kaléo, are provided below:



(In Thousands)	June 30, 2016		December 31, 2015			June 30, 2016			December 31, 2015
Assets:					Liabilities & Equity:
Cash & short-term investments	$	96,804	$	91,844
Restricted cash	35		8,182
Other current assets	36,273		9,070		Current liabilities	$	53,175		$	10,261
Property & equipment	14,762		8,453		Long term debt, net	143,040			142,696
Patents	2,875		2,811		Other noncurrent liabilities	689			552
Other long-term assets	114		92		Equity	(46,041		)	(33,057		)
Total assets	$	150,863	$	120,452	Total liabilities & equity	$	150,863		$	120,452



	Three Months Ended June 30,						Six Months Ended June 30,
	2016			2015			2016			2015
Revenues & Expenses:
Revenues, net (a)	$	15,020		$	10,068		$	11,970		$	14,918
Cost of goods sold	(3,987		)	(2,807		)	(7,608		)	(5,137		)
Expenses and other, net (b)	(18,139		)	(14,006		)	(17,598		)	(28,390		)
Income tax benefit (expense)	—			—			(9		)	(4		)
Net income (loss)	$	(7,106	)	$	(6,745	)	$	(13,245	)	$	(18,613	)
(a) Revenues were negative during the first quarter of 2016 relating to the impact of product sales allowances on channel inventory following a product price reset during the quarter. (b) “Expenses and other, net” includes selling, general and administrative expense, research and development expense, gain on contract termination, interest expense and other income (expense), net. Excluding the gain on contract termination recognized in the first quarter of 2016, “Expenses and other, net” would have been a net deduction of $18.7 million and $35.7 million in the second quarter and first six months of 2016, respectively.